4X6T
M.tuberculosis betalactamase complexed with inhibitor EC19
Summary for 4X6T
Entry DOI | 10.2210/pdb4x6t/pdb |
Descriptor | Beta-lactamase, PHOSPHATE ION, 3-[(2R)-2-(dihydroxyboranyl)-2-{[(2R)-2-{[(4-ethyl-2,3-dioxo-3,4-dihydropyrazin-1(2H)-yl)carbonyl]amino}-2-(4-hydroxyphenyl)acetyl]amino}ethyl]benzoic acid, ... (4 entities in total) |
Functional Keywords | beta-lactamase, transition state inhibitor, structure based drug development, beta-lactams, boronates, penicillin binding protein., hydrolase-hydrolase inhibitor complex, hydrolase/hydrolase inhibitor |
Biological source | Mycobacterium tuberculosis |
Cellular location | Cell inner membrane : P9WKD3 |
Total number of polymer chains | 1 |
Total formula weight | 29317.72 |
Authors | Hazra, S. (deposition date: 2014-12-09, release date: 2015-12-23, Last modification date: 2023-09-27) |
Primary citation | Kurz, S.G.,Hazra, S.,Bethel, C.R.,Romagnoli, C.,Caselli, E.,Prati, F.,Blanchard, J.S.,Bonomo, R.A. Inhibiting the beta-Lactamase of Mycobacterium tuberculosis (Mtb) with Novel Boronic Acid Transition-State Inhibitors (BATSIs). ACS Infect Dis, 1:234-242, 2015 Cited by PubMed: 27622739DOI: 10.1021/acsinfecdis.5b00003 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (1.4 Å) |
Structure validation
Download full validation report